Mycenax Biotech Inc. (TPEX: 4726)

Mycenax Biotech Revenue

Mycenax Biotech had revenue of 209.13M TWD in the quarter ending September 30, 2024, with 84.64% growth. This brings the company's revenue in the last twelve months to 672.85M, up 1.09% year-over-year. In the year 2023, Mycenax Biotech had annual revenue of 652.62M, down -10.88%.

• Revenue (ttm): 672.85M
• Revenue Growth: +1.09%
• P/S Ratio: 13.88
• Revenue / Employee: 1.74M
• Employees: 387
• Market Cap: 9.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	652.62M	-79.66M	-10.88%
Dec 31, 2022	732.28M	-41.99M	-5.42%
Dec 31, 2021	774.27M	108.93M	16.37%
Dec 31, 2020	665.34M	274.50M	70.23%
Dec 31, 2019	390.84M	179.42M	84.86%